CHESS ROBERT 4
4 · NEKTAR THERAPEUTICS · Filed Sep 20, 2023
Insider Transaction Report
Form 4
CHESS ROBERT
Director
Transactions
- Sale
Common Stock
2022-09-22$0.67/sh−10,200$6,834→ 274,773 total - Award
Stock Option
2023-09-19+85,000→ 85,000 totalExercise: $0.68Exp: 2031-09-18→ Common Stock (85,000 underlying)
Holdings
- 2,100(indirect: by son)
Common Stock
- 2,100(indirect: by daughter)
Common Stock
- 2,100(indirect: by daughter)
Common Stock
Footnotes (5)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $0.66 to $0.69. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
- [F3]Includes 56,794 shares previously reported as shares held in Grantor Retained Annuity Trusts for which the reporting person was the sole trustee.
- [F4]The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.
- [F5]This stock option vests in equal monthly installments over the one-year period beginning on September 19, 2023.